Request Demo
Last update 08 May 2025
JYP-0322
Last update 08 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with JYP-0322NCT06128148
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of JYP0322 in Patients With Solid Tumors
CTR20220684
JYP0322 在ROS1 基因融合阳性局部晚期/转移性实体瘤患者中安全 性、耐受性、药代动力学特征及初步有效性的I 期临床研究
[Translation] A Phase I clinical study of the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of JYP0322 in patients with ROS1 gene fusion-positive locally advanced/metastatic solid tumors
100 Clinical Results associated with JYP-0322
Login to view more data
100 Translational Medicine associated with JYP-0322
Login to view more data
100 Patents (Medical) associated with JYP-0322
Login to view more data
100 Deals associated with JYP-0322
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glioma | Phase 1 | China | 04 May 2022 | |
| Non-Small Cell Lung Cancer | Phase 1 | China | 04 May 2022 | |
| ROS1 positive Solid Tumors | Phase 1 | China | 04 May 2022 | |
| ROS1 fusion positive Neoplasms | Phase 1 | China | 11 Apr 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
NCT06128148 (AACR2025) Manual  | Phase 1 | 73 | (G2032R mutations) | (ffdavfxyqf) = zwbsldrcoq jpkxiyylwx (vfrycgslnb ) View more | Positive | 28 Apr 2025 | |
(G2032R mutations + Lorlatinib pretreated) | (ffdavfxyqf) = fwlksjzhkt jpkxiyylwx (vfrycgslnb ) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free